1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,585 | 4,630 | 12:12 | |
| 4,585 | 4,630 | 12:09 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| IMPLANTICA Aktie jetzt für 0€ handeln | |||||
| 10.12. | Implantica strengthens market expansion as Italy's leading Careggi University Hospital in Florence introduces RefluxStop | 309 | PR Newswire | VADUZ, Liechtenstein, Dec. 10, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device... ► Artikel lesen | |
| 25.11. | Implantica: RefluxStop 'Best in Class' at Japan Foregut Conference as 5-Year Data and Extensive Safety Cohort is Presented to 120 Leading Surgeons | 267 | PR Newswire | VADUZ, Liechtenstein, Nov. 25, 2025 /PRNewswire/ -- Implantica AG (publ), a medtech company at the forefront of introducing advanced technology into the body, announced today that its innovative... ► Artikel lesen | |
| 25.11. | IMPLANTICA: RefluxStop "Best in Class" at Japan Foregut Conference as 5-Year Data and Extensive Safety Cohort is Presented to 120 Leading Surgeons | 5 | Cision News | ||
| 11.11. | Implantica: RefluxStop takes center stage at 2025 European Foregut Society meeting | 328 | PR Newswire | VADUZ, Liechtenstein, Nov. 11, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique... ► Artikel lesen | |
| 31.10. | Implantica publishes Interim Report January - September 2025 (Q3) | 286 | PR Newswire | VADUZ, Liechtenstein, Oct. 31, 2025 /PRNewswire/ --
RefluxStop® Nears FDA Approval - Strong Momentum Toward US Market Entry
Significant events in the... ► Artikel lesen | |
| 27.10. | Implantica presents the third quarter 2025 on October 31 at 15:00 CET | 251 | PR Newswire | VADUZ, Liechtenstein, Oct. 27, 2025 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the third quarter 2025 at 15:00 CET on October 31. The interim report... ► Artikel lesen | |
| 13.10. | Implantica completes FDA 100-Day Meeting for RefluxStop PMA application | 319 | PR Newswire | VADUZ, Liechtenstein, Oct. 13, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative... ► Artikel lesen | |
| 06.10. | Implantica Successfully Completes MDSAP Recertification Audit | 301 | PR Newswire | VADUZ, Liechtenstein, Oct. 6, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative... ► Artikel lesen | |
| 25.09. | Implantica steps up to close the treatment gap with RefluxStop as main device competitor exits Europe and the UK | 402 | PR Newswire | VADUZ, Liechtenstein, Sept. 25, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device... ► Artikel lesen | |
| 24.09. | Implantica announces U.S. FDA has provided feedback on the final RefluxStop PMA submission, Module 3 | 316 | PR Newswire | VADUZ, Liechtenstein, Sept. 24, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device... ► Artikel lesen | |
| 17.09. | Implantica's RefluxStop sparks strong excitement at the American Foregut Society meeting, ahead of pending US FDA approval | 401 | PR Newswire | VADUZ, Liechtenstein, Sept. 17, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop®... ► Artikel lesen | |
| 10.09. | Implantica announces the payment of share rewards based on the AGM approved share-based incentive program as a directed share issue of own shares of the company without consideration | 6 | Cision News | ||
| 10.09. | Implantica ramps-up production with 10,000 RefluxStop units in preparation for U.S. launch, pending FDA PMA approval | 341 | PR Newswire | VADUZ, Liechtenstein, Sept. 10, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop®... ► Artikel lesen | |
| 14.08. | Implantica publishes Interim Report January - June 2025 (Q2) | 438 | PR Newswire | VADUZ, Liechtenstein, Aug. 14, 2025 /PRNewswire/ --
Transforming Clinical Excellence of RefluxStop® into Strategic Market Momentum
Significant events in the second quarter of 2025
FDA... ► Artikel lesen | |
| 13.08. | Implantica finishes new multi-cavity production tool for RefluxStop to support manufacturing ramp-up in the U.S. pending FDA approval | 381 | PR Newswire | VADUZ, Liechtenstein, Aug. 13, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop®... ► Artikel lesen | |
| 07.08. | Implantica presents the second quarter 2025 on August 14 at 15:00 CEST | 314 | PR Newswire | VADUZ, Liechtenstein, Aug. 7, 2025 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the second quarter 2025 at 15:00 CEST on August 14. The interim report for the... ► Artikel lesen | |
| 07.08. | Implantica announces second publication of groundbreaking 5-year results from the landmark RefluxStop clinical study | 376 | PR Newswire | VADUZ, Liechtenstein, Aug. 7, 2025 /PRNewswire/ -- Implantica AG (publ), a leading medtech company pioneering advanced implantable medical technologies, today announced the second peer-reviewed... ► Artikel lesen | |
| 01.07. | Implantica announces publication of the landmark RefluxStop 5-year clinical study results demonstrating excellent long-term success | 410 | PR Newswire | VADUZ, Liechtenstein, July 1, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of treatment for acid reflux with its unique device RefluxStop®, a treatment field... ► Artikel lesen | |
| 24.06. | Implantica submits the last and final module 3 of the FDA PMA Application for RefluxStop for US market approval | 491 | PR Newswire | VADUZ, Liechtenstein, June 24, 2025 /PRNewswire/ -- Implantica AG (publ.), a MedTech company at the forefront of introducing advanced technology into the body, including the unique device... ► Artikel lesen | |
| 17.06. | Implantica announces successful UK RefluxStop Users Meeting addressing growing demand after the final and positive UK NICE recommendations on use of RefluxStop in NHS public hospitals | 446 | PR Newswire | VADUZ, Liechtenstein, June 17, 2025 /PRNewswire/ -- Implantica AG (publ.), a MedTech company at the forefront of treatment for acid reflux with its unique device RefluxStop, a treatment field... ► Artikel lesen |
1 2 Weiter >>
40 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 48,690 | 0,00 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,490 | -0,30 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,590 | -0,20 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers vor Zahlen zum ersten Geschäftsquartal auf "Buy" mit einem Kursziel von 60 Euro belassen. Der Medizintechnikkonzern... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 40,100 | -1,33 % | CARL ZEISS MEDITEC AG stürzt ab - Panik im TecDAX! | ||
| ECKERT & ZIEGLER | 15,310 | +0,20 % | ECKERT & ZIEGLER SE zündet heute den Kursturbo! | ||
| UNITEDHEALTH | 279,85 | +0,14 % | UNITEDHEALTH GROUP INC kippt - jetzt zählt jede Minute | ||
| DRAEGERWERK | 68,90 | -0,58 % | EQS-News: Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014: Erwerb eigener Aktien - Abschlussmeldung | EQS-News: Drägerwerk AG & Co. KGaA
/ Schlagwort(e): Sonstiges
Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014: Erwerb eigener... ► Artikel lesen | |
| MEDTRONIC | 81,68 | -0,01 % | Dividendenbekanntmachungen (26.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALERUS FINANCIAL CORPORATION US01446U1034 0,21 USD 0,1782 EUR ALTRIA GROUP INC US02209S1033 1,06 USD 0,8999 EUR ARROWMARK FINANCIAL... ► Artikel lesen | |
| GERRESHEIMER | 27,620 | +0,14 % | Gerresheimer-Aktie: Gute Einstiegschance? | Aktionäre von Gerresheimer mussten im laufenden Jahr erhebliche Verluste hinnehmen. Der Kurs sank von 70 € zum Jahresbeginn bis auf 23,50 €. Zuletzt konnte er sich wieder berappeln und steht am Montag... ► Artikel lesen | |
| INTUITIVE SURGICAL | 484,80 | -0,84 % | Is ISRG's 20% Procedure Growth the New Normal or a Peak? | ||
| THERMO FISHER | 498,05 | +0,20 % | What to Expect From Thermo Fisher Scientific's Next Quarterly Earnings Report | ||
| TELADOC HEALTH | 5,957 | +1,26 % | HIMS vs. TDOC: Which Telehealth Stock Looks More Compelling? | ||
| STRATEC | 22,500 | 0,00 % | Aktien Frankfurt: Dax vorweihnachtlich träge | FRANKFURT (dpa-AFX) - Nach den moderaten Gewinnen am Freitag ist der deutsche Aktienmarkt etwas schwächer in die kurze Handelswoche vor Weihnachten gestartet. Das Geschehen ist von einem deutlich geringeren... ► Artikel lesen | |
| RHOEN-KLINIKUM | 12,700 | 0,00 % | Zulassung virtuelle Institutionsausweise für Krankenhäuser: RISE startet mit DKTIG & RHÖN-KLINIKUM AG die Friendly User Tests in der PU | Wien/Berlin (ots) - Das HSM-B ersetzt zukünftig den Institutionsausweis SMC-B und ermöglicht damit den Einsatz von virtuellen Institutionsausweisen beim RISE HSK im EigenbetriebDie gematik hat RISE... ► Artikel lesen | |
| GENEDX | 129,34 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen |
Das Unternehmen IMPLANTICA AG SDR kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,090 (+2,01 %) liegt der Kurs bei 4,565 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IMPLANTICA AG SDR finden Sie auf Wallstreet Online.